Articles of Vaccines

News »

Cuba reports 1,039 Covid-19 new cases and five deaths

covid-cuba-enfermo

The national director of Epidemiology at the Cuban Ministry of Public Health (MINSAP), Dr. Francisco Duran, reported 1,039 new Covid-19 cases and five deaths over the last 24 hours. At his regular press conference on television on Sunday, Dr. Duran explained that 18,156 PCR tests in real time were made to detect the SARS-CoV-2 coronavirus, which causes Covid-19.

News »

Cuba improves health protocols, produces Covid-19 vaccine candidates

Soberana-02

Cuba is currently improving its health protocols to fight the Covid-19 pandemic, while producing its most-advanced vaccine candidate, ¨Soberana 02¨, on a large scale, in order to begin phase III of clinical trials in March. During the latest meeting of the temporary working group, it was insisted on the need to speed up the results of the PCR tests.

News »

Cuba scales up industrial production of candidate vaccines

Cuba Vacunas

Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities. Cuba has begun the process of scaling up industrial production of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19.

News »

A million doses of COVID-19 vaccines to be available in April

mesa redonda biocubafarma

The director of the Finlay Vaccine Institute, Vicente Vérez Bencomo, stated that mass production of the Soberana series of candidate vaccines has begun, and Cuba can expect to have one million doses on hand in April. He explained that the manufacturing process is underway for 100,000 doses to supply broader clinical trials of Soberana 01 and Soberana 02.

News »

Everything to know to date about the four Cuban vaccine candidates against COVID-19

Soberana-01

Cuba currently has four vaccine candidates in clinical trials. What are the characteristics of each one? What results have they produced so far? What steps is the country taking to confront the new strains of the SARS-CoV2 virus? To learn about these issues, the president of BioCubaFarma, the general director of the Center for Genetic Engineering and Biotechnology, the general director of the Finlay Vaccine Institute.

News »

Itolizumab monoclonal antibody in the COVID-19 battle

interferon cuba

In 2014 the novel medication won a National Award from the Cuban Academy of Sciences (ACC) in the Biomedical Sciences arena, and since April, this year, the humanized monoclonal antibody, Itolizumab, has been included in the country’s COVID-19 treatment protocol. To learn first-hand about the characteristics and indications of this drug, created at the Center for Molecular Immunology (CIM), and winner of the World Intellectual Property Organization (WIPO) Gold Medal in 2015.

News »

Cuba, Vietnam Favor More Cooperation between Vaccine Producers

vacuna2

The Finlay Vaccine Institute (IFV) in Cuba and its Vietnamese counterpart, Vabiotech, signed a memorandum of understanding in this capital to boost cooperation relations. The document establishes the access to new technologies and products in an advanced stage as a key aspect, as well as new markets and possibilities of development, IFV Deputy Director Yury Valdes told Prensa Latina.